{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:26:04Z","timestamp":1780511164293,"version":"3.54.1"},"reference-count":52,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.3934\/mbe.2019364","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T05:05:07Z","timestamp":1565240707000},"page":"7250-7298","source":"Crossref","is-referenced-by-count":11,"title":["Compartment models for vaccine effectiveness and non-specific effects for Tuberculosis"],"prefix":"10.3934","volume":"16","author":[{"given":"Sarah","family":"Treibert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"1 Albert-Ludwigs-Universit\u00e4t Freiburg, Ernst-Zermelo Strasse 1, 79104 Freiburg, Germany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"2 Medizinische Fakult\u00e4t, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf, Universit\u00e4tsstrasse 1, 40225 D\u00fcsseldorf, Germany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"3 Center for Health Economics and Health Services Research, Bergische Universit\u00e4t Wuppertal, Gaussstrasse 20, 42119 Wuppertal, Germany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"4 Lehrstuhl f\u00fcr Angewandte Mathematik und Numerische Analysis, Bergische Universit\u00e4t Wuppertal, Gaussstrasse 20, 42119 Wuppertal, Germany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2321","reference":[{"key":"2","article-title":"K. Bozorgmehr, C. Stock, B. Joggerst, et al., Tuberculosis screening in asylum seekers in","unstructured":"2. K. Bozorgmehr, C. Stock, B. Joggerst, et al., Tuberculosis screening in asylum seekers in Germany: a need for better data, <em>The Lancet,<\/em> 3 (2018), Pe359\u2013e361."},{"key":"3","article-title":"K. Bozorgmehr, S. Preussler, U. Wagner, et al., Using country of origin to inform targeted tuberculosis screening in asylum","unstructured":"3. K. Bozorgmehr, S. Preussler, U. Wagner, et al., Using country of origin to inform targeted tuberculosis screening in asylum seekers: a modelling study of screening data in a German federal state, 2002-2015, <em>BMC Infect. Diseases,<\/em> 19 (2019), 304."},{"key":"5","article-title":"H. Guoand J. Wu, Persistenthigh incidence of tuberculosisamong immigrants in alow-incidence","unstructured":"5. H. Guoand J. Wu, Persistenthigh incidence of tuberculosisamong immigrants in alow-incidence country: impact of immigrants with early or late latency, <em>Math. Biosci. Eng.,<\/em> 8 (2011), 695\u2013709."},{"key":"8","article-title":"R. W. Aldridge, D. Zenner, P. J. White, et al., Tuberculosis in migrants moving from high-incidence to low-incidence","unstructured":"8. R. W. Aldridge, D. Zenner, P. J. White, et al., Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland, The Lancet, October 11, 2016."},{"key":"12","article-title":"M. Pareek, C. Greenaway, T. Noori, et al., The impact of migration on tuberculosis epidemiology and control in high-income","unstructured":"12. M. Pareek, C. Greenaway, T. Noori, et al., The impact of migration on tuberculosis epidemiology and control in high-income countries: a review, <em>BMC Med.,<\/em> 14 (2016), 48."},{"key":"15","article-title":"Y. Zhou and H. Cao, Discrete tuberculosis models and their application,","unstructured":"15. Y. Zhou and H. Cao, Discrete tuberculosis models and their application, in: S. Sivaloganathan (ed.), <em>New Perspectives in Mathematical Biology,<\/em> Fields Institute Communications 57, 2010."},{"key":"16","article-title":"R. Loddenkemper, J. F. Murray, C. Gradmann, et al., History of tuberculosis, Chapter 2","unstructured":"16. R. Loddenkemper, J. F. Murray, C. Gradmann, et al., History of tuberculosis, Chapter 2 in: G.B. Migliori, G. Bothamley, R. Duarte, A. Rendon (eds.) <em>Tuberculosis,<\/em> ERS Monograph 82, 2018."},{"key":"18","article-title":"J. P. Higgins, K. Soares-Weiser, J. A. Lopez-Lopez, et al., Association of BCG, DTP, and measles containing vaccines with childhood","unstructured":"18. J. P. Higgins, K. Soares-Weiser, J. A. Lopez-Lopez, et al., Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review, <em>BMJ,<\/em> 355 (2016), i5170."},{"key":"19","article-title":"P. Aaby, T. R. Kollmann and C. S. Benn, Nonspecific effects of neonatal and infant","unstructured":"19. P. Aaby, T. R. Kollmann and C. S. Benn, Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges, <em>Nat. Immunol.,<\/em> 15 (2014), 895\u2013899."},{"key":"20","article-title":"S. Biering-S\u00f8rensen, K. J. Jensen, I. Monterio, et al., Rapid protective effects of early BCG on neonatal mortality among low birth weight","unstructured":"20. S. Biering-S\u00f8rensen, K. J. Jensen, I. Monterio, et al., Rapid protective effects of early BCG on neonatal mortality among low birth weight boys: Observations from randomized trials, <em>J. Infect. Dis.,<\/em> 217 (2018), 759\u2013766."},{"key":"21","article-title":"V. Nankabirwa, J. K. Tumwine, O. Namugga, et al., Early versus late BCG vaccination in HIV-1-exposed infants in","unstructured":"21. V. Nankabirwa, J. K. Tumwine, O. Namugga, et al., Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial, <em>Trials,<\/em> 18 (2017), 152\u2013169."},{"key":"22","article-title":"M. G. Netea, L. A. Joosten, E. Latz, et al., Trained","unstructured":"22. M. G. Netea, L. A. Joosten, E. Latz, et al., Trained immunity: A program of innate immune memory in health and disease, <em>Science,<\/em> 352 (2016), aaf1098."},{"key":"23","article-title":"M. G. Netea, J. Quintin and J. van der Meer, <em>Trained","unstructured":"23. M. G. Netea, J. Quintin and J. van der Meer, <em>Trained Immunity: A memory for innate host defense,<\/em> Cell Press, Cell Host and Microbe, 2011."},{"key":"24","article-title":"M. G. Netea, Training innate","unstructured":"24. M. G. Netea, Training innate immunity: The changing concept of immunological memory in innate host defence, <em>Eur. J. Clin. Invest.,<\/em> 43 (2013), 881\u2013884."},{"key":"29","article-title":"K. L\u00f6nnroth, G. B. Migliori, I. Abubakar, et al., Towards tuberculosis","unstructured":"29. K. L\u00f6nnroth, G. B. Migliori, I. Abubakar, et al., Towards tuberculosis elimination: an action framework for low-incidence countries, <em>Eur. Respir. J.,<\/em> 45 (2015), 928\u2013952."},{"key":"33","article-title":"A. Roy, M. Eisenhut, R. J. Harris, et al., Effect of BCG vaccination against Mycobacterium tuberculosis infection in","unstructured":"33. A. Roy, M. Eisenhut, R. J. Harris, et al., Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis, <em>BMJ,<\/em> 349 (2014), g4643."},{"key":"34","article-title":"C. A. Thaissa and S. H. E. Kaufmann, <em>Toward novel vaccines against","unstructured":"34. C. A. Thaissa and S. H. E. Kaufmann, <em>Toward novel vaccines against tuberculosis: Current hopes and obstacles,<\/em> Yale J. Biol. Med., 83 (2010), 209\u2013215."},{"key":"36","article-title":"C. S. Merle, S. S. Cunha and L. C. Rodrigues, BCG vaccination and leprosy","unstructured":"36. C. S. Merle, S. S. Cunha and L. C. Rodrigues, BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control, <em>Expert Rev. Vaccines,<\/em> 9 (2010), 209\u2013222."},{"key":"37","article-title":"S. Chen, N. Zhang, J. Shao, et al., Maintenance versus non-maintenance intravesical Bacillus Calmette-Gu\u00e9rin instillation for non-muscle invasive bladder","unstructured":"37. S. Chen, N. Zhang, J. Shao, et al., Maintenance versus non-maintenance intravesical Bacillus Calmette-Gu\u00e9rin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials, <em>Int. J. Surg.,<\/em> 52 (2018), 248\u2013257."},{"key":"38","article-title":"V. Nankabirwa, J. K. Tumwine, P. M. Mugaba, et al., Child survival and BCG","unstructured":"38. V. Nankabirwa, J. K. Tumwine, P. M. Mugaba, et al., Child survival and BCG vaccination: a community based prospective cohort study in Uganda, <em>BMC Public Health.,<\/em> 15 (2015), 175\u2013185."},{"key":"39","article-title":"M. G. Netea and R. van Crevel, BCG-induced","unstructured":"39. M. G. Netea and R. van Crevel, BCG-induced protection: Effects on innate immune memory, <em>Semin. Immunol.,<\/em> 26 (2014), 512\u2013517."},{"key":"40","article-title":"B. Freyne, A. Marchant, N. Curtis, et al., BCG-associated heterologous immunity, a historical","unstructured":"40. B. Freyne, A. Marchant, N. Curtis, et al., BCG-associated heterologous immunity, a historical perspective: experimental models and immunological mechanisms, <em>Trans. R. Soc. Trop. Med. Hyg.,<\/em> 109 (2015), 46\u201351."},{"key":"41","article-title":"P. Aaby, A. Roth, H. Ravn, et al., Randomized trial of BCG vaccination at birth to low-birth-weight","unstructured":"41. P. Aaby, A. Roth, H. Ravn, et al., Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?, <em>J. Infect. Dis.,<\/em> 204 (2011), 245\u2013252."},{"key":"42","article-title":"R. Kandasamy, M. Voysey, F. McQuaid, et al., Non-specific immunological effects of selected routine childhood","unstructured":"42. R. Kandasamy, M. Voysey, F. McQuaid, et al., Non-specific immunological effects of selected routine childhood immunisations: systematic review, <em>BMJ,<\/em> 355 (2016), i5225."},{"key":"43","article-title":"R. Ragonnet, J. Trauer, J. Denholm, et al., Vaccination programs for endemic","unstructured":"43. R. Ragonnet, J. Trauer, J. Denholm, et al., Vaccination programs for endemic infections: Modelling real versus apparent impacts of vaccine and infection characteristics, <em>Nature Sci, Rep,,<\/em> 5 (2015), 15468."},{"key":"45","article-title":"S. Sorup, M. Villumsen, H. Ravn, et al., Smallpox vaccination and all-cause infectious disease","unstructured":"45. S. Sorup, M. Villumsen, H. Ravn, et al., Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study, <em>Int. J. Epidemiol.,<\/em> 40 (2011), 955-963."},{"key":"48","article-title":"L. C. J. de Bree, V. A. C. M. Koeken, L. A. B. Joosten, et al., Non-specific effects of","unstructured":"48. L. C. J. de Bree, V. A. C. M. Koeken, L. A. B. Joosten, et al., Non-specific effects of vaccines: Current evidence and potential implications, <em>Semin. Immunol.,<\/em> 39 (2018), 35\u201343."},{"key":"49","article-title":"D. Uthayakumar, S. Paris, L. Chapat, et al., Non-specific Effects of Vaccines Illustrated Through the BCG","unstructured":"49. D. Uthayakumar, S. Paris, L. Chapat, et al., Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations, <em>Front. Immunol.,<\/em> 9 (2018), Article 2869."},{"key":"50","article-title":"C. S. Benn, A. B. Fisker, A. Rieckmann, et al., How to evaluate potential non-specific effects of","unstructured":"50. C. S. Benn, A. B. Fisker, A. Rieckmann, et al., How to evaluate potential non-specific effects of vaccines: the quest for randomized trials or time for triangulation?, <em>Expert Rev. Vaccines,<\/em> 17 (2018), 411\u2013420."},{"key":"53","article-title":"J. Leentjens, M. Kox, R. Stokman, et al., BCG vaccination enhances the immunogenicity of subsequent Influenza vaccination in healthy","unstructured":"53. J. Leentjens, M. Kox, R. Stokman, et al., BCG vaccination enhances the immunogenicity of subsequent Influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study, <em>J. Infect. Dis.,<\/em> 212 (2015), 1930\u20131938."},{"key":"55","article-title":"L. G. Stensballe, S. S\u00f8rup, P. Aaby, et al., BCG vaccination at birth and early childhood","unstructured":"55. L. G. Stensballe, S. S\u00f8rup, P. Aaby, et al., BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial, <em>Arch. Dis. Child.,<\/em> 102 (2017), 224\u2013231."},{"key":"56","article-title":"L. G. Stensballe, H. Ravn, N. Birk, et al., BCG vaccination at birth and rate of hospitalization for Infection until 15 months of age in Danish","unstructured":"56. L. G. Stensballe, H. Ravn, N. Birk, et al., BCG vaccination at birth and rate of hospitalization for Infection until 15 months of age in Danish children: A randomized clinical multicenter trial, <em>J. Pediatric Infect. Dis. Soc.,<\/em> 2018."},{"key":"58","article-title":"S. Prentice, E. L. Webb, H. M. Dockrell, et al., Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan","unstructured":"58. S. Prentice, E. L. Webb, H. M. Dockrell, et al., Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial, <em>Trials,<\/em> 16 (2015), 149\u2013161."},{"key":"59","article-title":"C. S. Benn, A. B. Fisker, H. C. Whittle, et al., Revaccination with live attenuated vaccines confer additional beneficial nonspecific effects on overall","unstructured":"59. C. S. Benn, A. B. Fisker, H. C. Whittle, et al., Revaccination with live attenuated vaccines confer additional beneficial nonspecific effects on overall survival: A review, <em>EBioMedicine,<\/em> 10 (2016), 312\u2013317."},{"key":"60","article-title":"N. M. Birk, T. N. Nissen, J. Kj\u00e6gaard, et al., Effects of Bacillus Calmette-Gu\u00e9rin (BCG) vaccination at birth on T and B lymphocyte","unstructured":"60. N. M. Birk, T. N. Nissen, J. Kj\u00e6gaard, et al., Effects of Bacillus Calmette-Gu\u00e9rin (BCG) vaccination at birth on T and B lymphocyte subsets: Results from a clinical randomized trial, <em>Sci. Rep.,<\/em> 7 (2017), 12398."},{"key":"63","article-title":"Y. L. Lee, J. Y. Lee, Y. H. Jang, et al., Non-specific effects of","unstructured":"63. Y. L. Lee, J. Y. Lee, Y. H. Jang, et al., Non-specific effects of vaccines: immediate protection against Respiratory Syncytial Virus infection by Line Attenuated Influenza Vaccine, <em>Front. Microbiol.,<\/em> 9 (2018), Article 83."},{"key":"66","article-title":"G. A. Weinberg and P. G. Szilagy, Vaccine","unstructured":"66. G. A. Weinberg and P. G. Szilagy, Vaccine epidemiology: Efficacy, effectiveness, and the translational research road map, <em>J. Infect. Dis.,<\/em> 201 (2010), 1607\u20131610."},{"key":"67","article-title":"M. L. McHugh, The odds","unstructured":"67. M. L. McHugh, The odds ratio: calculation, usage, and interpretation, <em>Biochemica Medica,<\/em> 19 (2009), 120\u2013126."},{"key":"72","article-title":"WHO, Surveillance Report, 2012\u20132017, available","unstructured":"72. WHO, Surveillance Report, 2012\u20132017, available from: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/ecdc-tuberculosis-surveillance-monitoring-Europe-2017.pdf"},{"key":"73","article-title":"WHO, <em>Vaccine-preventable diseases: monitoring system 2018 global summary,<\/em> available","unstructured":"73. WHO, <em>Vaccine-preventable diseases: monitoring system 2018 global summary,<\/em> available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/ tswucoveragebcg.html"},{"key":"76","article-title":"Health Data, <em>South Sudan,<\/em> available","unstructured":"76. Health Data, <em>South Sudan,<\/em> available from: http:\/\/www.healthdata.org\/south-sudan"},{"key":"77","article-title":"Health Data, <em>Guinea-Bissau,<\/em> available","unstructured":"77. Health Data, <em>Guinea-Bissau,<\/em> available from: http:\/\/www.healthdata.org\/guinea-bissau"},{"key":"78","article-title":"Index Mundi, <em>Country Comparison: Guinea-Bissau vs. South Sudan,<\/em> available from:","unstructured":"78. Index Mundi, <em>Country Comparison: Guinea-Bissau vs. South Sudan,<\/em> available from: http: \/\/www.indexmundi.com\/factbook\/compare\/guinea-bissau.south-sudan"},{"key":"79","article-title":"WHO, Vaccine-preventable diseases: monitoring system 2018 global summary, Guinea Bissau, available","unstructured":"79. WHO, Vaccine-preventable diseases: monitoring system 2018 global summary, Guinea Bissau, available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/estimates?c=GNB"},{"key":"80","article-title":"WHO, Vaccine-preventable diseases: monitoring system 2018 global summary, South Sudan, available","unstructured":"80. WHO, Vaccine-preventable diseases: monitoring system 2018 global summary, South Sudan, available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/coverages?c=SSD"},{"key":"81","article-title":"UN, available","unstructured":"81. UN, available from: http:\/\/www.childmortality.org\/files_v20\/download\/IGME% 20Report%202015_9_3%20LR%20Web.pdf (Inter-agency Group for Child Mortality Estimation, 2010\u20132015)"},{"key":"82","article-title":"UNICEF, available","unstructured":"82. UNICEF, available from: http:\/\/data.unicef.org\/resources\/state-worlds-children-2016-statistical-tables\/ (2007\u20132016)"},{"key":"83","article-title":"P. Mangtani, P. Nguipdop-Djomo, R. H. Keogh, et al., The duration of protection of school-aged BCG vaccination in","unstructured":"83. P. Mangtani, P. Nguipdop-Djomo, R. H. Keogh, et al., The duration of protection of school-aged BCG vaccination in England: a population-based case\u2013control study, <em>Int. J. Epidemiol.,<\/em> 47 (2017), 193\u2013201."},{"key":"93","article-title":"L. J. S. Allen, An Introduction to Stochastic Epidemic Models,","unstructured":"93. L. J. S. Allen, An Introduction to Stochastic Epidemic Models, in: F. Brauer, P. van den Driessche, J. Wu (eds.), Mathematical Epidemiology. Lecture Notes in Mathematics 1945, Springer, Berlin, Heidelberg, pp 81\u2013130."},{"key":"100","article-title":"B. Song, C. Castillo-Chavez andJ. P. Aparicio, Tuberculosis models withfast and","unstructured":"100. B. Song, C. Castillo-Chavez andJ. P. Aparicio, Tuberculosis models withfast and slowdynamics: The role of close and casual contacts, <em>Math. Biosci.,<\/em> 180 (2002), 187\u2013205."},{"key":"101","article-title":"D. Bichara and A. Iggidr, Multi-patch and multi-group epidemic","unstructured":"101. D. Bichara and A. Iggidr, Multi-patch and multi-group epidemic models: a new framework, <em>J. Math. Biol.,<\/em> 77 (2018), 107\u2013134."},{"key":"106","article-title":"N. Blaser, C. Zahnda, S. Hermans, et al., Tuberculosis in Cape","unstructured":"106. N. Blaser, C. Zahnda, S. Hermans, et al., Tuberculosis in Cape Town: An age-structured transmission model, <em>Epidemics,<\/em> 14 (2016), 54\u201361."}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aimspress.com\/article\/10.3934\/mbe.2019364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T05:05:07Z","timestamp":1565240707000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/10.3934\/mbe.2019364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2019364","relation":{},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}